Detalhe da pesquisa
1.
A review on the added value of whole-body MRI in metastatic lobular breast cancer.
Eur Radiol
; 32(9): 6514-6525, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35384456
2.
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study.
Lancet
; 395(10241): 1919-1926, 2020 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32473682
3.
Posterior reversible encephalopathy syndrome associated with use of Atezolizumab for the treatment of relapsed triple negative breast cancer.
Cancer Treat Res Commun
; 31: 100548, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35305364
4.
Does the addition of whole-body MRI to routine imaging influence real-world treatment decisions in metastatic breast cancer?
Cancer Imaging
; 22(1): 26, 2022 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35672838
5.
Evaluating a digital tool for supporting breast cancer patients: a randomized controlled trial protocol (ADAPT).
Trials
; 21(1): 86, 2020 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31941539
6.
EN2 in Prostate Cancer.
Adv Clin Chem
; 71: 47-76, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26411411
7.
Engrailed homeobox transcription factors as potential markers and targets in cancer.
FEBS Lett
; 587(6): 549-54, 2013 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-23395604
8.
EN2: a novel prostate cancer biomarker.
Biomark Med
; 7(6): 893-901, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24266821
9.
Chemotherapy for breast cancer in pregnancy: evidence and guidance for oncologists.
Ther Adv Med Oncol
; 3(2): 73-83, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21789157
10.
Bleomycin-induced Raynaud's phenomenon after single-dose exposure: risk factors and treatment with intravenous iloprost infusion.
J Clin Oncol
; 31(4): e51-2, 2013 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23270004